Why PDL Income Generating Transactions are Important to Investors
Building Value for Our Stockholders
PDL expects to create additional stockholder value beyond our Queen et. al. patents by pursuing opportunities with key innovators to bring new income generating assets with attractive returns to PDL. Income from these transactions will fund the payment of dividends after PDL no longer receives royalties from the Queen et. al. patents.
We focus on income generating assets in the life science and healthcare market. We have the ability to provide monetization of royalties, debt financing and other innovative financing solutions to private and publicly traded companies at late stages of development to help them reach critical growth and commercialization milestones.
Our investments are typically in assets with strong intellectual property protection and current near term product commercialization opportunities.